Literature DB >> 11734674

Lifestyle factors and coagulation activation markers: the Caerphilly Study.

J W Yarnell1, P M Sweetnam, A Rumley, G D Lowe.   

Abstract

Coagulation activation markers are being investigated as risk factors for cardiovascular disease; we examined the contribution of several lifestyle factors to variation in plasma levels of several activation markers measured in a population-based study of 1947 men. Smoking, alcohol, body mass index (BMI), leisure and work activity, social class, and use of prescribed medicines were each examined in turn. Specific assays of fibrin D-dimer and von Willebrand factor (vWF) activity showed similar relationships to lifestyle variables as we observed previously for less specific assays of D-dimer and vWF antigen. D-dimer levels increased with age, in smokers and in men taking prescribed medication, and were negatively associated with leisure time activity. vWF activity increased with age and showed a U-shaped distribution with BMI. Factors VIIc and VIIIc and thrombin-antithrombin complexes were associated with BMI, factor VIIIc and prothrombin fragments 1 + 2 (F1 + 2) were associated with age, activated partial thromboplastin time (aPTT) and F1 + 2 were associated with smoking, and aPTT showed a small negative association with alcohol consumption. We conclude that lifestyle modification has the possibility of favourably influencing several of these risk markers. In particular, cigarette smoking has a possibly reversible effect on coagulation activation (measured by F1 + 2 and D-dimer).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734674     DOI: 10.1097/00001721-200112000-00015

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  10 in total

1.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

Authors:  Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

2.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

3.  Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition.

Authors:  Johann Otto Pelz; Kristian Harms; Michael Metze; Dominik Michalski
Journal:  J Neurol       Date:  2017-12-09       Impact factor: 4.849

4.  Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV.

Authors:  Patricia A Cioe; Jason Baker; Erna M Kojic; Nur Onen; John Hammer; Pragna Patel; Christopher W Kahler
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

5.  Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Vincenzo Marottoli; Alessia Arcaro; Luigi Iannaccone; Fabrizio Gentile; Maurizio Maraglione
Journal:  J Thromb Thrombolysis       Date:  2022-08-02       Impact factor: 5.221

6.  Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD.

Authors:  Naushad Ahmad Khan; Mradul Kumar Daga; Istaq Ahmad; Govind Mawari; Suman Kumar; Naresh Kumar; Syed Akhter Husain
Journal:  J Inflamm Res       Date:  2016-11-18

7.  Effectiveness of Embolization of Inferior Mesenteric Artery to Prevent Type II Endoleak Following Endovascular Aneurysm Repair: A Review of the Literature.

Authors:  Makoto Samura; Noriyasu Morikage; Takahiro Mizoguchi; Yuriko Takeuchi; Takashi Nagase; Takasuke Harada; Kotaro Suehiro; Kimikazu Hamano
Journal:  Ann Vasc Dis       Date:  2018-09-25

8.  IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Martijn A Spruit; Jeanine J Houwing-Duistermaat; Daniel Kotz; Valéria Lima Passos; Emiel F M Wouters
Journal:  BMC Med Genet       Date:  2009-03-09       Impact factor: 2.103

Review 9.  Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Yun-Jiu Cheng; Zhi-Hao Liu; Feng-Juan Yao; Wu-Tao Zeng; Dong-Dan Zheng; Yu-Gang Dong; Su-Hua Wu
Journal:  PLoS Med       Date:  2013-09-17       Impact factor: 11.069

Review 10.  Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis.

Authors:  Yuhong Mi; Shufeng Yan; Yanhui Lu; Ying Liang; Chunsheng Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.